Centrum Medyczne ENEL-MED S.A. (WSE:ENE)
Poland · Delayed Price · Currency is PLN 19.00
0.00 (0.00%)
Jul 6, 2026, 11:00 AM CET
Centrum Medyczne ENEL-MED Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 885.29 | 854.27 | 735.59 | 616.77 | 494.9 | 441.14 |
| 885.29 | 854.27 | 735.59 | 616.77 | 494.9 | 441.14 | |
Revenue Growth (YoY) | 16.05% | 16.13% | 19.27% | 24.62% | 12.19% | 10.34% |
Cost of Revenue | 801.59 | 774.62 | 677.09 | 589.43 | 484.02 | 419 |
Gross Profit | 83.7 | 79.64 | 58.51 | 27.34 | 10.88 | 22.14 |
Selling, General & Admin | 61 | 58.32 | 35.54 | 32.9 | 37.12 | 23.82 |
Other Operating Expenses | -2.22 | -1.77 | 0.08 | -9.07 | -6.54 | -3.73 |
Operating Expenses | 58.78 | 56.55 | 35.62 | 23.84 | 30.58 | 20.09 |
Operating Income | 24.92 | 23.09 | 22.89 | 3.5 | -19.7 | 2.06 |
Interest Expense | -7.02 | - | -10.43 | -10.16 | -5.82 | -5.33 |
Interest & Investment Income | - | 1.31 | 1.24 | 1.64 | 2.46 | 1.64 |
Currency Exchange Gain (Loss) | 2.2 | 2.2 | 3.12 | 14.61 | -2.83 | 0.61 |
Other Non Operating Income (Expenses) | -10.21 | -10.21 | -2 | -0.02 | -0.01 | -0.01 |
EBT Excluding Unusual Items | 9.89 | 16.39 | 14.82 | 9.57 | -25.89 | -1.03 |
Merger & Restructuring Charges | - | - | 3.55 | - | - | - |
Gain (Loss) on Sale of Investments | -0.03 | -0.03 | -0.01 | -0.04 | -0.77 | - |
Gain (Loss) on Sale of Assets | -0.77 | -0.77 | -0.13 | -3.72 | -1.28 | -0.1 |
Legal Settlements | -0.01 | -0.01 | -0 | -0.04 | - | -0.02 |
Other Unusual Items | 0.72 | 0.72 | 0.93 | 3.13 | - | 1.24 |
Pretax Income | 9.81 | 16.31 | 19.14 | 8.89 | -27.94 | 0.1 |
Income Tax Expense | 2.1 | 3.42 | 4.54 | 0.97 | -4.38 | 1.51 |
Earnings From Continuing Operations | 7.71 | 12.89 | 14.61 | 7.93 | -23.56 | -1.41 |
Net Income | 7.71 | 12.89 | 14.61 | 7.93 | -23.56 | -1.41 |
Net Income to Common | 7.71 | 12.89 | 14.61 | 7.93 | -23.56 | -1.41 |
Net Income Growth | -60.27% | -11.75% | 84.27% | - | - | - |
Shares Outstanding (Basic) | 28 | 28 | 28 | 28 | 28 | 24 |
Shares Outstanding (Diluted) | 28 | 28 | 28 | 28 | 28 | 24 |
Shares Change (YoY) | - | - | - | - | 17.55% | 2.08% |
EPS (Basic) | 0.27 | 0.46 | 0.52 | 0.28 | -0.83 | -0.06 |
EPS (Diluted) | 0.27 | 0.46 | 0.52 | 0.28 | -0.83 | -0.06 |
EPS Growth | -60.65% | -11.75% | 84.49% | - | - | - |
Free Cash Flow | 23.5 | 31.96 | 58.34 | 55.17 | -5.9 | 28.55 |
Free Cash Flow Per Share | 0.83 | 1.13 | 2.06 | 1.95 | -0.21 | 1.19 |
Gross Margin | 9.45% | 9.32% | 7.95% | 4.43% | 2.20% | 5.02% |
Operating Margin | 2.81% | 2.70% | 3.11% | 0.57% | -3.98% | 0.47% |
Profit Margin | 0.87% | 1.51% | 1.99% | 1.29% | -4.76% | -0.32% |
Free Cash Flow Margin | 2.65% | 3.74% | 7.93% | 8.95% | -1.19% | 6.47% |
EBITDA | 49.87 | 58.05 | 51.14 | 29.63 | 5.53 | 24.79 |
EBITDA Margin | 5.63% | 6.79% | 6.95% | 4.80% | 1.12% | 5.62% |
D&A For EBITDA | 24.95 | 34.95 | 28.25 | 26.13 | 25.22 | 22.73 |
EBIT | 24.92 | 23.09 | 22.89 | 3.5 | -19.7 | 2.06 |
EBIT Margin | 2.81% | 2.70% | 3.11% | 0.57% | -3.98% | 0.47% |
Effective Tax Rate | 21.39% | 20.95% | 23.69% | 10.86% | - | 1568.75% |